Evidence map›Paper›PMID 25198727›Full record

ArticlePloS one2014

Protozoacidal Trojan-Horse: use of a ligand-lytic peptide for selective destruction of symbiotic protozoa within termite guts.

Amit Sethi, Jennifer Delatte, Lane Foil, Claudia Husseneder

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Ligand-lytic peptides for specific targeting ofFrontiers in cellular and infection microbiology · 2025
    Article
  2. Gut yeast diversity ofFrontiers in microbiology · 2024
    Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Amit SethiDepartment of Entomology, Louisiana State University Agricultural Center, Baton Rouge, Louisiana, United States of America.
Jennifer DelatteDepartment of Entomology, Louisiana State University Agricultural Center, Baton Rouge, Louisiana, United States of America.
Lane FoilDepartment of Entomology, Louisiana State University Agricultural Center, Baton Rouge, Louisiana, United States of America.
Claudia HussenederDepartment of Entomology, Louisiana State University Agricultural Center, Baton Rouge, Louisiana, United States of America.
Louisiana State University Agricultural Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For novel biotechnology-based termite control, we developed a cellulose bait containing freeze-dried genetically engineered yeast which expresses a protozoacidal lytic peptide attached to a protozoa-recognizing ligand. The yeast acts as a 'Trojan-Horse' that kills the cellulose-digesting protozoa in the termite gut, which leads to the death of termites, presumably due to inefficient cellulose digestion. The ligand targets the lytic peptide specifically to protozoa, thereby increasing its protozoacidal efficiency while protecting non-target organisms. After ingestion of the bait, the yeast propagates in the termite's gut and is spread throughout the termite colony via social interactions. This novel paratransgenesis-based strategy could be a good supplement for current termite control using fortified biological control agents in addition to chemical insecticides. Moreover, this ligand-lytic peptide system could be used for drug development to selectively target disease-causing protozoa in humans or other vertebrates.

Indexed as

Host-Parasite InteractionsSymbiosisAnimalsEukaryotaIntestinesIsopteraLigandsPeptidesPest Control, BiologicalLigandsPeptides

Identifiers

PMID25198727
PMCPMC4157778
OpenAlexW1990013554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.